| Articles | Study design | Participants mean or median age | TBI severity | Type of beta-blockers used | Dosage of beta-blockers | Beta-blockers were used | Non-beta-blockers drugs | Length of stay | Mortality rate |
| Choi et al. [8] | Narrative review | 26 | Moderate, severe | Propranolol | N/A | In combination | Morphine, baclofen, gabapentin, benzodiazepines, bromocriptine | N/A | N/A |
| Diamond et al. [21] | Case report | 35.5 | Severe | Labetalol | 10 mg | In combination | Morphine | N/A | N/A |
| Feng et al. [22] | Narrative review | 18.1 | Severe | Propranolol | 40 mg q12 h IV | In combination | Morphine, baclofen, gabapentin, benzodiazepine, bromocriptine, clonidine, dexmedetomidine, dantrolene | N/A | N/A |
| Godoy et al. [23] | Letter to the editor | 28 | Moderate, severe | Propranolol | 20 mg q12 h to 20 mg q8 h IV | In combination | Morphine, fentanyl | N/A | N/A |
| Schroeppel et al. 2014 [24] | Case-control | 42 | Severe | Propranolol | 85 mg IV | Alone | N/A | 44 | 3 |
| Van der jagt and miranda. [25] | Review | 55 | Moderate, severe | Atenolol | 10 mg q6 h IV followed 100 mg q24 h orally | Alone | N/A | N/A | 5.1 |
| Garg et al. [26] | Case report | 26 | Severe | Propranolol | 10 mg q12 h to 10 mg q8 h IV | Alone | N/A | N/A | N/A |
| Monteiro et al. [27] | Case report | 27 | Severe | Propranolol | 10 mg q8 h | Alone | N/A | N/A | N/A |
| Zheng et al. [9] | Narrative review | 30 | Moderate, severe | Propranolol, labetalol, metoprolol | 20–60 mg q4-6 hr orally | In combination | α2-Agonists, gabapentin, baclofen, bromocriptine, and long-acting benzodiazepines | N/A | N/A |
| Ammar and Hussein [11] | Randomized, double-blinded, placebo-controlled trial | 55 | Moderate | Propranolol | 1 mg q6 hr IV | Alone | N/A | N/A | N/A |
|
|